作者: Miryam Martinetti , Annalisa De Silvestri , Cesare Belloni , Annamaria Pasi , Carmine Tinelli
关键词:
摘要: From 1991 to 1998 we vaccinated 4835 neonates against hepatitis B virus (HBV) and monitored their humoral response the recombinant vaccine. In a sample of 184 these babies studied association between HLA class I II genomic polymorphisms vaccine immune-mediated diseases. A subgroup 96 also underwent III (C4A C4B) typing. Four levels were identified, each with peculiar MHC restriction. Different products seem act as agonists (C4AQ0 HLA-DQB1(*)02) or antagonists (C4AQ0, HLA-DQB1(*)02, HLA-DRB1(*)11, DQB1(*)0301) in lowering HBV The group responders was characterized more for lacking "nonresponder" alleles than having specific "responder" ones. Tolerance peptides may have clinical implications, possibly being marker genetic risk immunopathologies. fact, many poor carried from two four HLA-DQ alpha beta heterodimers predisposing insulin-dependent diabetes mellitus celiac disease. Two true nonresponders suffered allergies slow had transient episodes hyperglycemia.